| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ecb5bcd71f1f2d0c314a9acdeda13e98 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-24 |
| filingDate |
2017-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d217ac4acbe7ca758fbdde79f09337e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94afe84d7c850173b9c3625ce773cdf4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19bbc7c173b4d06276b937ce876baa56 |
| publicationDate |
2018-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-107573292-A |
| titleOfInvention |
Pyrazine derivative compounds acting on prolyl hydroxylase |
| abstract |
The present invention relates to pyrazine derivative compounds useful in the treatment of hypoxia inducible factor mediated and/or erythropoietin related conditions. The pyrazine derivative compound of the present invention has the following structure: Formula (I). |
| priorityDate |
2017-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |